-
Subject Areas on Research
-
A falling out following minoxidil: telogen effluvium.
-
A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer.
-
A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
-
A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
-
A spontaneous deletion within the desmoglein 3 extracellular domain of mice results in hypomorphic protein expression, immunodeficiency, and a wasting disease phenotype.
-
Adriamycin in the treatment of childhood acute leukemia. A Southwest Oncology Group study.
-
Adriamycin in the treatment of childhood solid tumors. A Southwest Oncology Group study.
-
Alopecia associated with fluconazole therapy.
-
Alopecia in IL-10-deficient mouse pups is c-kit-dependent and can be triggered by iron deficiency.
-
Alopecia: evaluation and management.
-
Authors' reply.
-
Basal cell carcinoma originating from a nevus sebaceus on the scalp of a 7-year-old boy.
-
Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies.
-
Central centrifugal cicatricial alopecia.
-
Central hair loss in African American women: incidence and potential risk factors.
-
Central scalp alopecia photographic scale in African American women.
-
Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches.
-
Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss.
-
Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study.
-
Correspondence re: E. Hawk, et al., Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the First National Health and Nutrition Examination Survey. Cancer Epidemiol.Biomark. Prev., 9: 523-527, 2000.
-
Current and novel methods for assessing efficacy of hair growth promoters in pattern hair loss.
-
Cyclic Alopecia and Abnormal Epidermal Cornification in Zdhhc13-Deficient Mice Reveal the Importance of Palmitoylation in Hair and Skin Differentiation.
-
Dose-response study of topical minoxidil in male pattern baldness.
-
Dosimetric analysis of the alopecia preventing effect of hippocampus sparing whole brain radiation therapy.
-
Early onset baldness and prostate cancer risk.
-
Ectodermal dysplasia: otolaryngologic manifestations and management.
-
Effect of ultraviolet light on topical minoxidil-induced hair growth in advanced male pattern baldness.
-
Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded Study.
-
Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss.
-
Efficacy of finasteride 1 mg in the treatment of androgenetic alopecia in men.
-
Evaluation and treatment of male and female pattern hair loss.
-
Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee.
-
Female pattern hair loss and its relationship to permanent/cicatricial alopecia: a new perspective.
-
Female pattern hair loss.
-
Female pattern hair loss.
-
Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.
-
Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil.
-
Focal atrichia: A diagnostic clue in female pattern hair loss.
-
Frontal fibrosing alopecia: a retrospective review of 19 patients seen at Duke University.
-
Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo.
-
Guidelines of care for androgenetic alopecia. American Academy of Dermatology.
-
Hair loss among elderly men: etiology and impact on perceived age.
-
Human FOXN1-deficiency is associated with αβ double-negative and FoxP3+ T-cell expansions that are distinctly modulated upon thymic transplantation.
-
Human equivalent of the mouse Nude/SCID phenotype: long-term evaluation of immunologic reconstitution after bone marrow transplantation.
-
Iron deficiency and hair loss: the jury is still out.
-
Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups.
-
Keratosis follicularis spinulosa decalvans in a family.
-
Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
-
Long-term follow-up of men with male pattern baldness treated with topical minoxidil.
-
Mice with alopecia, osteoporosis, and systemic amyloidosis due to mutation in Zdhhc13, a gene coding for palmitoyl acyltransferase.
-
Multiple phenotypic changes in mice after knockout of the B3gnt5 gene, encoding Lc3 synthase--a key enzyme in lacto-neolacto ganglioside synthesis.
-
My hair is thinning on the top of my head. What treatments are available for hair loss in women?
-
Occupational alopecia or alopecia areata?
-
Persistent Rash in a Patient Receiving Total Parenteral Nutrition.
-
Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial.
-
Phase II study of docetaxel in advanced soft tissue sarcomas.
-
Pityriasis amiantacea: a report of two cases in adults.
-
Quality of life of cutaneous disease in the ectodermal dysplasias.
-
Resource utilization and quality of life associated with congenital ichthyoses.
-
SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss.
-
Scalp comedones after topical minoxidil.
-
Serum androgens: associations with prostate cancer risk and hair patterning.
-
Serum androgens: associations with prostate cancer risk and hair patterning.
-
Skin manifestations in individuals of African or Asian descent.
-
Summary of North American Hair Research Society (NAHRS)-sponsored Workshop on Cicatricial Alopecia, Duke University Medical Center, February 10 and 11, 2001.
-
The Danish Twin Registry in the new millennium.
-
The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.
-
The midline part: an important physical clue to the clinical diagnosis of androgenetic alopecia in women.
-
The near-naked hairless (Hr(N)) mutation disrupts hair formation but is not due to a mutation in the Hairless coding region.
-
Tinea capitis mimicking dissecting cellulitis.
-
Topical minoxidil in early male pattern baldness.
-
Topical minoxidil in male pattern baldness: effects of discontinuation of treatment.
-
Transdermal viprostol in the treatment of male pattern baldness.
-
Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study.
-
Treatment of chemotherapy-induced alopecia.
-
Update on cicatricial alopecia.
-
Keywords of People